Amplia Therapeutics Limited
INNMF
$0.12
-$0.005-4.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.27M | -4.20M | -4.08M | -3.51M | -2.96M |
| Total Depreciation and Amortization | 55.90K | 56.80K | 57.10K | 56.70K | 56.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.00K | 1.42M | 2.73M | 1.39M | 39.80K |
| Change in Net Operating Assets | -341.50K | -435.70K | -521.10K | -521.10K | -521.10K |
| Cash from Operations | -4.43M | -3.16M | -1.82M | -2.58M | -3.38M |
| Capital Expenditure | -1.20K | -1.40K | -1.60K | -1.50K | -1.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.20K | -1.40K | -1.60K | -1.50K | -1.40K |
| Total Debt Issued | -- | 733.50K | 1.47M | 1.47M | 1.47M |
| Total Debt Repaid | -1.55M | -2.60M | -3.65M | -2.91M | -2.18M |
| Issuance of Common Stock | 17.28M | 10.77M | 4.27M | 2.13M | 200.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.41M | -910.20K | -409.40K | -234.80K | -60.20K |
| Cash from Financing | 9.22M | 5.24M | 1.12M | 301.20K | -506.60K |
| Foreign Exchange rate Adjustments | 28.90K | 9.40K | -10.90K | 4.80K | 20.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.81M | 2.09M | -707.60K | -2.28M | -3.87M |